Neurology Medical News about apomorphine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The pragmatic use of apomorphine at the end of life
Palliative Medicine, 10/30/09

Dewhurst F et al. – Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short–acting D1/D2 dopamine agonist administered sub–cutaneously that is used in the treatment of PD. This case highlights its potential benefits for symptom control at the end of life.

<< Previous
Therapeutic Conversation to Improve Mood in Nursing Home...

Next >>
Frequency of migraine and the risk of cardiovascular disease for...

The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations: A Pilot Study
Clinical Neuropharmacology, 10/02/09 Relevance Score: 88%

Inhalation Device Allows Novel Administration of Apomorphine in Men with Erectile Dysfunction - Efficacy and Safety Findings
The Journal of Sexual Medicine, 10/30/09 Relevance Score: 87%

The ANKK1 Gene Associated with Addictions Is Expressed in Astroglial Cells and Upregulated by Apomorphine
Biological Psychiatry, 10/28/09 Relevance Score: 83%